Skip to main navigation
Skip to search
Skip to main content
UNT Health Home
Search content at UNT Health
Home
Research units
Profiles
Publications
Sponsored Projects
Core Facilities
Window of opportunity: Estrogen as a treatment for ischemic stroke
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Window of opportunity: Estrogen as a treatment for ischemic stroke'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Acute Treatment
40%
Adverse Effects
20%
Clinical Conditions
20%
Clinical Trials
100%
Combined Therapy
20%
Estrogen
100%
Estrogen Replacement Therapy
80%
Estrogen Treatment
40%
Experimental Ischemic Stroke
20%
Experimental Stroke
40%
Hormone Therapy
20%
In Vivo Model
20%
Ischemic Stroke
100%
Ischemic Stroke Models
20%
Mistranslation
20%
Neurodegenerative Diseases
20%
Neuroprotectant
20%
Neuroprotection
20%
Neuroprotective Action
20%
Neurovascular Unit
20%
Postmenopausal Women
20%
Potential Interaction
20%
Primary Stroke Prevention
20%
Protective Behavior
20%
Protective Effect
20%
Recombinant Tissue Plasminogen Activator (rt-PA)
40%
Research Trials
20%
Secondary Stroke Prevention
20%
Stroke Prevention
20%
Stroke Research
40%
Treatment Paradigms
20%
Window of Opportunity
100%
Neuroscience
Adverse Effect
14%
Alteplase
28%
Biological Marker
14%
Brain Ischemia
100%
Cerebrovascular Accident
85%
Critical Period
14%
Estrogen
100%
Estrogen Replacement Therapy
57%
Hormone Therapy
14%
In Vitro
14%
In Vivo
14%
Neurodegenerative Disorder
14%
Neuroprotection
14%
Neuroprotective Agent
14%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Effect
9%
Alteplase
18%
Biological Marker
9%
Brain Ischemia
100%
Cerebrovascular Accident
36%
Clinical Trial
45%
Degenerative Disease
9%
Endocrine Therapy
9%
Estrogen
100%
Experimental Stroke
18%
Neuroprotection
9%
Neuroprotective Agent
9%
Replacement Therapy
36%
Psychology
Adverse Effect
20%
Clinical Trial
100%
Critical Period
20%